Who
Warner Weston Biddle
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Kyverna Therapeutics.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Apr 2024
- Last trade
- 13 Mar 2026
- Last filed
- 17 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Mar 2026filed 17 Mar 2026 | KYTX Kyverna TherapeuticsBiotechnology | SEC FORM 4 Code A | —58,000 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | KYTX Kyverna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | KYTX Kyverna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | KYTX Kyverna TherapeuticsBiotechnology | SEC FORM 4 Code A | —58,000 at $0.00 | filing |
| 16 Sep 2024filed 18 Sep 2024 | KYTX Kyverna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,579,259 at $0.00 | filing |
| 11 Apr 2024filed 15 Apr 2025 | KYTX Kyverna Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —332,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.